Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia

BACKGROUND: In 2004, Ethiopia switched its first-line treatment of uncomplicated Plasmodium falciparum malaria from sulphadoxine-pyrimethamine to a fixed artemisinin-based combination therapy (ACT), artemether-lumefantrine (AL). Patient adherence to AL regimen is a major determining factor to achiev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemma, Hailemariam, Löfgren, Curt, San Sebastian, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248875/
https://www.ncbi.nlm.nih.gov/pubmed/22141751
http://dx.doi.org/10.1186/1475-2875-10-349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248875/
https://www.ncbi.nlm.nih.gov/pubmed/22141751
http://dx.doi.org/10.1186/1475-2875-10-349

Ejemplares similares